ARA-290 10MG

ARA-290 (Cibinetide) – 10 mg

Lyophilized Research Peptide

ARA-290, also known as Cibinetide, is a synthetic peptide engineered from a specific structural domain of erythropoietin (EPO). It is designed to selectively activate tissue-protective signaling pathways without stimulating erythropoiesis. This functional selectivity makes ARA-290 a subject of ongoing laboratory investigation in inflammation modulation and cellular repair mechanisms.

Unlike full-length erythropoietin, ARA-290 is studied for its interaction with the innate repair receptor (IRR), a receptor complex associated with tissue protection and immune response regulation. Due to this targeted activity profile, it is frequently incorporated into experimental models examining inflammatory signaling, neuropathic responses, and regenerative processes.

This product is supplied as a high-purity lyophilized peptide for controlled laboratory research use.

Product Specifications

• Peptide Name: ARA-290 (Cibinetide)
• Purity: >98%
• Form: Lyophilized powder
• Quantity: 10 mg per vial
• Storage Conditions:
• Store at -20°C (-4°F) prior to reconstitution
• After reconstitution, store at 2–8°C (36–46°F)
• Use within 30 days of reconstitution

• Classification: Research use only

Areas of Laboratory Investigation

ARA-290 is commonly studied in controlled research environments involving:

• Anti-inflammatory signaling pathway analysis
• Neuropathic pain model development
• Tissue protection and regenerative response studies
• Innate repair receptor (IRR) mechanism exploration
• Cytokine modulation and immune-response research

Important Notice

This compound is intended strictly for laboratory research purposes.
It is not approved for human consumption, clinical use, or therapeutic application.
This product is not intended to diagnose, treat, cure, or prevent any disease.